Mirum Pharmaceuticals (MIRM) Research & Development (2019 - 2026)

Mirum Pharmaceuticals' Research & Development history runs 8 years deep, the most recent figure standing at $97.9 million for Q1 2026.

• In Q1 2026, Research & Development rose 138.55% year-over-year to $97.9 million; the TTM figure through Mar 2026 stood at $238.0 million (up 59.28% YoY), while the FY2025 annual figure was $186.2 million, up 32.39% from the prior year.
• Research & Development for Q1 2026 stood at $97.9 million, up from $51.1 million in the prior quarter.
• The five-year high for Research & Development was $97.9 million in Q1 2026, with the low at $22.0 million in Q2 2023.
• The 5-year median for Research & Development is $31.7 million (2024), against an average of $37.0 million.
• The sharpest annual moves came in 2022 and 2026: Research & Development tumbled 36.83% in 2022, then surged 138.55% in 2026.
• Mirum Pharmaceuticals' Research & Development stood at $31.1 million in 2022, then slipped by 0.55% to $30.9 million in 2023, then surged by 42.32% to $44.0 million in 2024, then climbed by 16.08% to $51.1 million in 2025, then surged by 91.58% to $97.9 million in 2026.
• Business Quant data shows MIRM's Research & Development at $97.9 million in Q1 2026, $51.1 million in Q4 2025, and $43.0 million in Q3 2025.